# Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis

> **NCT02882438** · PHASE1 · UNKNOWN · sponsor: **Ahmed A. H. Abdellatif** · enrollment: 30 (estimated)

## Conditions studied

- Foot Infection Tinea Pedis

## Interventions

- **DRUG:** infected group
- **DRUG:** control group

## Key facts

- **NCT ID:** NCT02882438
- **Lead sponsor:** Ahmed A. H. Abdellatif
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2020-09
- **Final completion:** 2022-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02882438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02882438, "Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02882438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*